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doi:10.1016/j.ejvs.2011.04.021Abstract Objectives and design: Undelayed investigation and surgical treatment of symp-
tomatic carotid artery stenosis are recommended as per guidelines on stroke prevention. We
evaluated patient referral pathways and delays from symptom to surgery in Helsinki University
Central Hospital (HUCH) region.
Materials and methods: One hundred consecutive symptomatic patients scheduled for carotid
endarterectomy (CEA) between August 2007 and September 2008 were identified and the delay
between ischaemic index symptom and CEA was analysed.
Results: The median time from the index symptom to surgery was 47 days (range: 3e688 days).
The longest delay was surgery related with a median of 25 days (range: 2e202 days) from the
consultation of the vascular surgeon to the operation. Only 11% of the patients were operated
within the recommended 2 weeks’ time. It was more likely that CEA was performed within 2
weeks if an emergent consultation to Meilahti Hospital neurologist on call did take place (odds
ratio (OR) 12.6, 95% confidence interval (CI) 1.5e104, p Z 0.019).
Conclusion: Delays from symptom to surgery were generally too long and the in-hospital door-
to-knife time (DKT) was long mostly due to waiting for the operation theatre. The investigation
of all stroke, amaurosis fugax and transient ischaemic attack patients should be performed on
an emergency basis and most optimally centralised to hospitals were carotid surgery is per-
formed.
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274 P. Vikatmaa et al.Carotid endarterectomy (CEA) remains the most effective
method of stroke prevention in symptomatic patients with
moderate and high-grade internal carotid artery (ICA)
stenosis at the proximity of carotid bifurcation. The atti-
tude towards the timing of the operation has changed over
a decade. Previously, it has been held appropriate to wait
for weeks after ischaemic stroke before CEA.1e3 Based on
post-hoc analysis of large randomised clinical trials (RCTs)
on symptomatic carotid stenosis,4e6 the current guidelines
recommend CEA within 2 weeks or less from the ischaemic
symptom to prevent recurrence.7e11 Lovett et al. reported
that a patient with a stroke due to large-artery athero-
sclerosis has a 12.6% risk of recurrent stroke within 1 month
and 19.2% risk within 3 months.12 Many of these strokes may
be potentially preventable by early CEA. This target seems
to have been out of reach; only 6% of UK patients were
operated within 2 weeks in the beginning of this decade,13
and only 7% of Swedish patients were operated within the
same time frame between 2004 and 2006.14 SomeTable 1 The demographics, medical history, medication, indica
contact patterns.
Age (years) (Mean, SD, (range))
Sex (Male%)
Smoking (%)
Hypertension (%)
Dyslipidemia (%)
Cardiac disease (%)a
Diabetes (%)
Antihypertensive medication (%)
Statin treatment (%)
Anti-platelet therapy (%)
Presenting symptom (%)
Afx
TIA
Stroke
minor stroke (mRs 0e2)
major stroke (mrs  3)
Miscellaneousb
Stenosis (%)
50e70%
70e99%
Contralateral occlusion/stenosis (%)
0e49%
50e99%
100%
First health-care system contact (N)
Health-care center
Seondary referral centres
Neurologist HUCH
Ophthalmologist
Private practitioner
Internal medicine
Neurologist outside HUCH
Surgical ward
Pain clinic
Afx Z amaurosis fugax; mRS Z modified Rankin Scale for the degree
a Cardiac disease including atrial fibrillation, CAD, congestive heart
b “Miscellaneous” are patients who were difficult to categorize clea
same level of urgency and therefore included in the delay analysis. (development has occurred as Halliday et al. reported that
20% of patients had their operation within 2 weeks from
symptom onset in the UK between 2005 and 2007.15 Simi-
larly, the median time from preceding symptom to opera-
tion was only 12 days in the latest Swedvasc report,
although the variation between hospitals was still large in
Sweden.16
Theoretically, operating the right patients at the right
time gives a great advantage in the form of low numbers
needed to treat (NNT) in stroke prevention.8 Compared
with other subtypes, patients with stroke due to large-
artery atherosclerosis have been shown to have the high-
est odds of recurrent stroke at 7 days (odds ratio
(OR) Z 3.3, 95% confidence interval (CI) Z 1.5e7.0). This
subtype accounted for 37% of recurrences within 7 days,
which underlines the need for urgent carotid assessment
and treatment.12 Several factors have been identified to
increase the surgical risk if the CEA is performed early after
symptoms. As stated by Naylor,8 there may be patienttions for CEA, radiological characteristics and first health-care
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failure, artificial valve, aortic stenosis, cardiomyopathy.
rly to any of the symptomatic groups, but were operated with the
See results for details).
Delay in Carotid Surgery 275subgroups in whom one should avoid early surgery: (i)
evidence of recent carotid occlusion, (ii) modified Rankin
Scale score17 (mRS)  3, (iii) ischaemic infarct >two-thirds
of the middle cerebral artery territory, (iv) no neurological
plateau, (v) fluctuating conscious levels and (vi) evidence
of intracranial haemorrhage on computed tomography (CT)
scan. Conversely, a series of 226 CEA patients from three
European centres showed that patients ranked ASA 2 and/
or mRS 2 could safely undergo CEA within a waiting period
shorter than 28 days.18 The present scientific interest has
been mainly on treatment and outcome-related issues
instead of structural and process measures, which actually
might have the greatest value in stroke prevention.19
Reaching a 7-day target from symptom to treatment could
be a massive improvement in stroke prevention by CEA and
it has been quite clearly shown that it would prevent far
more strokes in the long term than surgical treatment of
large numbers of asymptomatic individuals.8
The study was carried out in order to have actual
numbers to support and plan the implementation of
minimal delays. We wanted to define patient referral
pathways and reasons for the delay from symptom to
surgery and to evaluate complications occurring during the
delay.Materials and Methods
The present study is a single-centre retrospective study
with data from a tertiary referral centre (Meilahti Hospital)
at Helsinki University Central Hospital (HUCH) and the data
represent a centralised system, where all CEAs in the region
(catchment area 1.5 million) are performed in this centre.
There were a number of different pathways through which
the patients were referred to HUCH (Table 1). After
approval by the local ethical committee, the records of 100
consecutive symptomatic patients scheduled for CEA at the
Department of Vascular Surgery between August 2007 and
September 2008 were retrieved. One hundred symptomatic
cases were calculated backwards from the operation
theatre schedule. The CEAs on asymptomatic patients from
the same time period were excluded.
During the study period, the updated European Stroke
Initiative recommendations for stroke management20 were
published and translated to Finnish and distributed with the
national weekly general medical journal, Finnish Medical
Journal (Suomen La¨a¨ka¨rilehti), to virtually all Finnish
doctors.21 The national guidelines (Current Care of
ischaemic stroke) recommended surgery as soon as possible
and ideally within 2 weeks from the latest symptom. Stroke
in evolution and crescendo transient ischaemic attack (TIA)
were considered emergent, that is, to be operated within
24 h during the first available daytime, and the rest of CEAs
were put on the first available elective list place.
The types of ischaemic symptoms and the first health-
care system contact were recorded among other patient
demographics (Table 1). The medical history data were
collected from the prospective HUSVASC registry22 and they
were defined as a pre-existing diagnosis or medical treat-
ment of diabetes mellitus (DM), dyslipidaemia, hyperten-
sion, cardiac disease (including atrial fibrillation, coronary
artery disease, congestive heart failure, aortic valvestenosis or cardiomyopathy) and smoking habits categorised
as a present smoker or non-smoker for >5 years. Additional
data on medical history were derived from the medical
records. The indication for CEA was recorded as amaurosis
fugax (AFX) only, other TIA symptoms, stroke or miscella-
neous symptoms. The miscellaneous patients were
included, because they represent patients who are often
excluded from studies, but were operated with the same
level of urgency in our series. The index stroke symptoms
were evaluated from the patient charts by a neurologist
(TS) and dichotomised as minor (mRS 0e2) or major
mRS  3. The data on medications included the preopera-
tive use of any anti-platelet regimens (including aspirin
(ASA), dipyridamole or clopidogrel), anticoagulant use
(warfarin or low-molecular-weight heparin, LMWH), anti-
hypertensive and lipid-lowering medications (statins).
The steps of the patient work-up were studied in detail
and are reported in days (d). The ‘patient-related delay’
was defined as the time from the first (‘index’) symptom to
health-care professional contact. The ‘referral delay’ was
the time from referral by a general practitioner or private
doctor to the patient actually meeting a neurologist. The
‘neurological delay’ was defined as the time from meeting
the first specialist (neurologist) to surgical consultation.
From within the neurological (diagnostic) delay, a ‘radio-
logical delay’ can be separated, which is the time between
referral to radiological investigation and performing the
investigation that gave enough information for the surgeon
to schedule the patient for operation. The radiological
delay could also overlap with the ‘surgical delay’, which
was defined as the time from first surgical consultation to
the actual operation. Within this surgical delay, details in
the waiting time were analysed in further detail.
In order to further evaluate the appropriateness of the
CEAs performed, the patients were divided into specific
groups identified from the large randomised trials’ sub-
analyses. In this process, sex, grade of stenosis and delay
from the index symptom to operation were used to classify
the patients.9
Statistical analysis
Distributions of the continuous variables were studied and
tested for normality. Univariate comparison between the
groups was performed with Student’s t-test or Man-
neWhitney rank sum test for continuous variables, and with
Pearson c2 test for discrete variables. All statistical anal-
yses used SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Two-sided
values of P < 0.05 were considered significant. For multi-
variate analysis testing associations with CEA delay less
than 2 weeks or one month, a model of logistic regression
including potential confounders as identified by univariate
analysis (P  0.20) was applied. The data are given as OR
(95% CI) with the corresponding P-value.
Results
One hundred consecutive CEA operations for symptomatic
ICA stenosis were identified. In one patient, carotid surgery
was deferred at the day of the planned operation due to
cardiac and pulmonary problems. During the same time
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< 2wk 2-4 wk 4-12 wk > 12 wk
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Figure 1 Delay categories from the index symptom to
surgery. Only 11% of the patients were operated within 2 weeks
and 32% of the patients were operated within 4 weeks.
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all CEAs) and 10 patients were treated by carotid stenting,
but not included in the present analysis.
The index symptom was afx in 19 (19%), TIA in 21 (21%)
and stroke in 46 (46%) patients. Among patients with stroke
as the index symptom (n Z 46), 11 patients (23.9%) had
mRS  3, that is, a major stroke at the time of surgery
(Table 1). Most of them, that is, eight patients (72.7%) had
moderate disability (mRS 3). Two patients had moderately
severe disability (mRS 4) and one patient was severely
disabled (mRS 5) prior to CEA. Symptoms were miscella-
neous in six patients (6%), including recurrent collapse
(n Z 3), recurrent episodes of diplopia and headache
(n Z 1), recurrent drop attacks (n Z 1) and an amnestic
episode (n Z 1).
Only 32% of the patients were operated within 4 weeks
and 11% within 2 weeks of their presenting symptom
(Figure 1). The patients with overall CEA delay less than 2
weeks (n Z 89) were younger with mean age of 63.7 (9.7)Table 2 Factors associated with CEA delay less than two week
Delay of CEA >2
weeks
N Z 89
<2
weeks
N Z 11
Univariate OR (95% CI
Gender,
Female;
n (%)
27
(30.3)
3 (27.3) 0.834 e
Age, mean
(SD)
69.4
(8.2)
63.7 (9.7) 0.038 0.9
(0.87e1.01
p Z 0.101
Stroke as
indexa
40
(48.2)b
6 (54.5) 0.692 e
Stenosis
70e99%
66
(74.2)
11 (100) 0.225 e
Emergency
contact
to HUCH
37
(41.6)
10 (90.9) 0.002 12.6
(1.5e104),
p Z 0.019
OR Z odds ratio; 95% CI Z 95% confidence interval.
a As opposed to TIA or AFX as index symptom.
b n Z 83 due to exclusion of patients with miscellaneous symptoms
c n Z 61 due to exclusion of patients with miscellaneous symptomsversus 69.4 (8.2) years of the patients with delay longer
than 2 weeks (nZ 11) (pZ 0.038). The CEA was more often
performed within 2 weeks, if HUCH neurologist or vascular
surgeon was consulted on an emergency basis or the patient
was referred to HUCH emergency unit. It was more likely
that CEA was performed within 2 weeks if an emergent
consultation to Meilahti Hospital neurologist on call did
take place (OR 12.6, 95% CI 1.5e104, pZ 0.019). The same
was true for having the operation within 1 month with an
OR of 6.1 (95%CI 2.4e15.8; p < 0.0001) (Table 2). Overall,
the emergency consultation or referral took place in about
half of the patients (47%; 47/100).
The median time from the index symptom to surgery was
47 d (3e688 d). The components of the delay are given in
Fig. 2. The total delay was significantly shorter if the index
symptom was a minor stroke with a median of 34 d, (range:
7e216 d) or a major stroke (median: 22 d; range: 8e102 d)
compared to AFX (median: 66 d; range: 9e688 d) or TIA
(median: 69 d; range: 3e216 d) (p < 0.005, Krus-
kalleWallis). The total delay was significantly shorter if the
patient was referred to HUCH as an emergency patient,
that is, during the first admission with a median of 31 d
from symptom to surgery (mean: 36 d, standard deviation
(SD): 32, range: 3e148 d) compared to elective admission
median of 69 d (mean: 95 d, SD: 70 d, range: 10e688 d;
p < 0.0001). If the vascular surgeon was consulted during
the first visit, the median total delay was 25 d (range:
3e148 d) versus 84 d when not consulted (range: 10e688 d;
p < 0.0001). Also, if the carotid examination was per-
formed urgently, the total delay was significantly shorter
compared to elective carotid artery examinations: Median
29 d (range: 5e148 d) versus 89 d (range: 21e688 d);
p < 0.0001.
During the delay from the first symptom to surgery 10
(10%) patients had recurrence or progression in their
symptoms, that is, recurrent TIA (nZ 2), progression of TIA
to minor stroke (n Z 2), progression of minor strokes or one month.
) >1
month
N Z 67
<1
month
N Z 33
Univariate OR (95% CI)
20 (29.9) 10 (30.3) 0.963 e
);
69.6 (8.5) 67.1 (8.6) 0.172 0.98
(0.93e1.03),
p Z 0.402
28 (45.9)c 18 (54.5) 0.424 e
50 (74.6) 27 (81.8) 0.579 e
22 (32.8) 25 (75.8) p > 0.0001 6.1
(2.4e15.8),
p < 0.0001
(n Z 6).
(n Z 6).
47 (3-688)
9 (0-262)
        0 (0-356)          0 (0-122)                            7 (0-170) 25 (2-202)
First symptoms
Patient goes to doctor
Patient sees the neurologist
Radiological examinations for the carotids
     Patient sees the vascular surgeon
Delays:     Operation takes place
patient related
referral
neurological
radiological
surgical
diagnostic
total
Figure 2 The structure of the delay from the index symptom to carotid endarterectomy in 100 symptomatic patients operated
in Helsinki University Central Hospital. Numbers are presented as median (range).
Delay in Carotid Surgery 277symptoms (n Z 2) or progression of symptoms from minor
to major stroke (n Z 2), or progression of major stroke
(n Z 2). All these patients underwent CEA and the median
(range) total delay for them was 8.5 (1e30) days.
There were two perioperative major strokes and one
minor stroke. These operations took place 9 and 52 d from
the index symptom. One further patient, operated 102 d
from a TIA, died on the 4th postoperative day. She had
postoperative headache, a generalised seizure and high
blood pressure postoperatively, but the transcranial
Doppler (TCD) finding and clinical picture were otherwise
untypical for hyperperfusion syndrome. In autopsy, the
cause of death was cerebral anoxy and the operated area
was smooth with no residual flaps. In addition, there were
one hyperperfusion syndrome, one TIA and three cranial
nerve injuries. Taken together, the rate of disabling stroke
and mortality was 3/100 (3%) and any stroke or death was
4/100 (4%).
When compared with the data of subgroup analysis from
the randomised studies,9 62% of the patients were operated
with a good benefit expectation (NNT < 7), 19% with
a reasonable benefit expectation (NNT 8e20) and 19% were
operated too late (Table 3).Table 3 All 100 CEA patients grouped according to their
respective theoretical number needed to treat based on
their sex, the degree of stenosis, and delay as derived from
the published NASCET and ECST subgroup data.6,9 The
colours represent different NNT groups. Green: NNT < 7
equivalent to best possible benefit; Yellow: NNT Z 8e20
equals to reasonable benefit; Red: operation theoretically
harmful for the patient (i.e. NNT can not be calculated).
Number of 
patients
Delay, symptom 
to surgery    
Degree of 
stenosis / 
gender
0-2 weeks 2-4 weeks 4-12 weeks > 12weeks 
70-99 % / 
male
8 11 19 16
70-99% / 
female 
3 4 10 6
50-69% / 
male
0 5 7 8
50-69% / 
female 
0 1 2 0Discussion
As the great majority of patients do not get their carotid
surgery in time and there are a number of patients with
disease progression while waiting, all efforts to speed up
the process are of great importance.
According to our practice, the neurologist is responsible
for the initial diagnosis and work-up and a vascular surgeon
is consulted when CEA is considered potentially indicated.
It could be criticised that 6.5% (3/46) of the stroke
patients were dependent on daily help or were bedridden
and thus their operative treatment should have been
reconsidered. On the other hand, almost three out of four
stroke patients had a preoperative status equivalent to the
requirements in the randomised trials. Our recruitment is
somewhat similar to the recently published International
Carotid Stenting Study (ICSS) study, in which 87% of the
patients randomised to either CEA or carotid stenting had
mRS 0e2, 12% had mRS 3e5 and was unknown in 2%.22
During the study period, carotid artery stenting (CAS)
was offered only for patients either who were considered
for randomisation in the ICSS study23 or who had a speci-
fied indication for CAS as recommended later by the
European guidelines.11 The operation planning schedule
was used for data collection in order to include also the
patients whose operations were cancelled due to patient-
related reasons.
Major complication rate for symptomatic CEA in the
present study (3%) did not differ from our data from 2000 to
2005.22 It is in line with other published reports when only
symptomatic patients are included.8
If the timing of surgery is accepted as an important
factor in patient flow, some changes in the treatment
protocols should be made. After realising that only 11% of
the patients were operated within 2 weeks, two additional
weekly empty operation slots were added to shorten delay.
In a busy on call hospital like ours, it still seems unjustified
to perform all CEAs on an emergency basis, but if there are
not enough planned slots (e.g., during holiday times) we
now operate also the stable patients on call. In addition, in
TIA patients with carotid symptoms the use of CT angio-
grams (CTA) on emergency basis has increased. When
a thrombolysis candidate is requested to have perfusion
imaging, a CTA covering the carotid bifurcation is also
included at present. Moreover, the vascular surgeon meets
278 P. Vikatmaa et al.the patients more often already at the emergency
department.
Systematic data like these need to be taken to hospital
administration in order to make the additional changes
needed. For best performance, the delay should be moni-
tored online in our case by a vascular co-ordinator team of
experienced specialised nurses. They manage all vascular
operational lists, patient contacts and monitor delays. To
improve communication, the in-hospital delay was nomi-
nated as door-to-knife time (DKT) equalling it with the
door-to-needle time (DNT) of thrombolysis treatment in
acute ischaemic stroke. For better areal coverage vascular
registries, such as Swedvasc in Sweden, have initiated this
culture of delay monitoring.16 Another important issue is to
raise public awareness and educate general practitioners to
send these patients as emergencies to the tertiary centre.
It is also possible to use subgroup NNTs, derived from the
large trials, as quality measures of CEA practice in hospitals
instead of only referring to overall complication rates as
these are strongly affected by timing and patient selection.
The lower the NNT (with acceptable complication rates) is,
the better is the quality of the practice, and more strokes
are prevented. Taking into account also the degree of
stenosis and sex, a theoretical traffic-light coded table of
our cohort could be produced (Table 3). Setting the ‘gold
standard’ as NNT < 7, 62% of the actually operated patients
met the indications, the rest with less benefit mainly due to
the delay. Furthermore, 19 patients were operated in
a situation where an NNT figure could not be calculated,
that is, the patients did not theoretically benefit from the
operation. When the indication was set more liberally, not
taking timing into account, all these patients met the
criteria, having a symptomatic moderate or high-grade ICA
stenosis. Of note, the analysis, which this information is
based upon, is all post-hoc sub-analysis of randomised
studies. No studies have randomised or are unlikely to
randomise symptomatic patients within different delay
categories. The studies have compared patients operated
within different time intervals with medically treated
patients, not randomised similar patients to be operated
within different time intervals. Emergency CEA for stroke in
evolution or crescendo TIA may carry a very high risk for
perioperative stroke or death (20.2% and 11.4%, respec-
tively), but for stable patients surgery seems not to carry an
elevated risk even if it is performed within 1 week from
symptom onset.24 It is somewhat confusing that males with
a high-grade stenosis, the group most likely to undergo CEA,
seem to have almost as many strokes prevented/1000
operations, irrespective of whether they were operated
within 2 weeks or >12 weeks from the index symptom.8 For
women with moderate or high-grade symptomatic carotid
stenosis, the benefit from CEA was only apparent in those
randomised within 2 weeks from their last symptomatic
ischaemic event. This group consisted of 190 women of
which 106 were operated with 10 complications.25 Thus,
these subgroups may not be large enough to make the
strong conclusions that have been presented and deny
treatment from any of the subgroups.
Local differences in consultation patterns may be
significant. Rapid-access TIA clinics are one way to tackle
the problem, but it is difficult to have all patients referred
to these clinics, which is underlined by our data on referralpathways (Table 1). Salem et al. reported that they could
operate 78% of 109 patients who were investigated in
a rapid-access TIA/minor stroke clinic, within 14 days of the
symptom without increased perioperative morbidity.
However, they excluded 53 symptomatic patients who were
operated in the same centre during the same time period,
but were from outside Leicesteshire, that is, were not
referred to the rapid-access clinic directly.26 From our data
it could be seen that the patients should be admitted on
call to the definite treatment centre, a vascular surgeon
should be involved early on in the decision-making process
and the DKT should be kept at minimum. If an emergent
evaluation system is to be implemented, the neurologists
and general practitioners in the area should be informed
and trained. However, this is ineffective if the tertiary
treatment hospital does not provide emergency service
with specialised interest in TIA, AFX and minor stroke
patients.27,28
Limitations of the study include at least the retrospec-
tive nature, small sample size and difficulties in catego-
rising patients who come from several different sources to
one clinic and finding the exact days of symptoms (e.g., ‘2
weeks ago’ was decided to be 14 days if not stated more
clearly). It may also be criticised that we included six
patients with symptoms that were not strictly hemispheric.
With this we wanted to underline that, despite the fact that
current scientific discussion focusses mainly on RCT-derived
results, we should not forget that the RCSTs represent only
a subset of patients and many patients, who would not have
been included in them, may still operated upon.29,30 In our
data, these six patients were operated with the same level
of urgency from their symptom and were thus similar from
the delay perspective. Despite these limitations, an anal-
ysis of an unselected consecutive patient material from
a well-defined population gives an interesting insight into
what really happens in everyday CEA practice.
Waiting time from symptom to surgery is generally too
long and, in our region, this was mostly due to waiting time
for the operation theatre and lack of appropriate
operation-related resources. Our results support that the
investigation of TIA and stroke patients should be per-
formed immediately and most optimally centralised to
hospitals where carotid surgery is performed.Acknowledgements
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